Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer
Veronica Mollica(Medica (Italy)), Francesco Massari(Altera (United States)), Alessia Cimadamore(University of Udine), Vincenzo Di Nunno(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Marina Scarpelli(Marche Polytechnic University), Liang Cheng(Brown University), Matteo Santoni(University of Macerata), Antonio López-Beltrán(University of Córdoba), Rodolfo Montironi(Marche Polytechnic University)
Cited by 44
Related Papers
Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
|Modern Pathology|2017|404
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
|Cancers|2021|289